Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma

被引：0
|
作者：
Yoshinami, Y. [1 ]
Yamamoto, S. [1 ]
Shiraishi, K. [1 ]
Itoyama, M. [1 ]
Imazeki, H. [1 ]
Yokoyama, K. [1 ]
Honma, Y. [1 ]
Kurita, D. [2 ]
Ishiyama, K. [2 ]
Oguma, J. [2 ]
Daiko, H. [2 ]
Kato, K. [1 ]
机构：
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
415P
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [2] The safety and short-term efficacy of neoadjuvant chemotherapy in elderly patients with resectable locally advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Seto, Yasuyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 433 - 433
  • [3] Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
    Wu, Zhigang
    Zheng, Qiang
    Chen, Haiquan
    Xiang, Jiaqing
    Hu, Hong
    Li, Hang
    Pan, Yunjian
    Peng, Yizhou
    Yao, Xingxin
    Liu, Pengcheng
    Sun, Yihua
    Li, Bin
    Zhang, Yawei
    JOURNAL OF THORACIC DISEASE, 2021, 13 (06) : 3518 - 3528
  • [4] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [5] Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin
    Toru Kadono
    Shun Yamamoto
    Toshiharu Hirose
    Go Ikeda
    Akihiro Ohara
    Mai Itoyama
    Kazuki Yokoyama
    Yoshitaka Honma
    Taiki Hashimoto
    Shigeki Sekine
    Koshiro Ishiyama
    Junya Oguma
    Hiroyuki Daiko
    Ken Kato
    Esophagus, 2023, 20 : 109 - 115
  • [6] Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin
    Kadono, Toru
    Yamamoto, Shun
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Hashimoto, Taiki
    Sekine, Shigeki
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    ESOPHAGUS, 2023, 20 (01) : 109 - 115
  • [7] Safety and short-term efficacy of preoperative FOLFOX therapy for patients with resectable esophageal squamous cell carcinoma who are not candidates for cisplatin
    Kadono, T.
    Yamamoto, S.
    Ohara, A.
    Itouyama, M.
    Yokoyama, K.
    Honma, Y.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Kato, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S250 - S250
  • [8] The safety and short-term efficacy of induction DCF plus nivolumab therapy in patients with unresectable locally advanced esophageal squamous cell carcinoma.
    Yamamoto, Shun
    Shiraishi, Kazuhiro
    Imazeki, Hiroshi
    Yoshinami, Yuri
    Ogura, Nozomu
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Kashihara, Tairo
    Hashimoto, Taiki
    Daiko, Hiroyuki
    Seto, Yasuyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 425 - 425
  • [9] Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.
    Okunaka, Mashiro
    Kotani, Daisuke
    Sato, Kazuma
    Fujiwara, Naoto
    Mishima, Saori
    Shitara, Kohei
    Fujita, Takeo
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 271 - 271
  • [10] Neoadjuvant chemoimmunotherapy was associated with better short-term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
    Duan, Xiaofeng
    Zhao, Fangdong
    Shang, Xiaobin
    Yue, Jie
    Chen, Chuangui
    Ma, Zhao
    Chen, Zuoyu
    Zhang, Chen
    Pang, Qingsong
    Zhang, Wencheng
    Abbas, Abbas E.
    Jiang, Hongjing
    CANCER MEDICINE, 2024, 13 (15):
12345